NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001057

Registered date:27/02/2008

Surveillance for early gastric cancer after endoscopic submucosal dissection and H.pylori eradication.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedEarly gastric cancer
Date of first enrollment2008/02/01
Target sample size100
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeRecurrence of gastric cancer after endoscopic submucosal dissection and Aberrant DNA methylation and aberrant expression of microRNAs, DNA, and proteins, including CD44v9, CagA and stemness-related factors, in gastric tumors and in background gastric mucosa such as atrophic and metaplastic mucosa
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients who have anticoagulant therapy. Patients who had total gastrectomy during the course observation. Patients who do not respond to 2nd eradication thrapy of H.pylori.

Related Information

Contact

public contact
Name Hidekazu Suzuki
Address 35 Shinanomachi, Shinjuku-ku, Tokyo Japan
Telephone 03-5363-3914
E-mail hsuzuki@a6.keio.jp
Affiliation Keio University, School of Medicine Division of Gastroenterology and Hepatology
scientific contact
Name Hidekazu Suzuki
Address 35 Shinanomachi, Shinjuku-ku, Tokyo Japan
Telephone 03-5363-3914
E-mail hsuzuki@a6.keio.jp
Affiliation Keio University, School of Medicine Division of Gastroenterology and Hepatology